GENERAL AMERICAN INVESTORS CO INC
Position in SPRY — ARS Pharmaceuticals, Inc.
CIK 40417
NEW YORK, NY
Position in SPRY
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$5,839,046
-$684,476 QoQ
Shares Held
727,154
+29.9% QoQ
Ownership
0.732%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GENERAL AMERICAN INVESTORS CO INC holds $52,562,960 across 6 Biotechnology names. SPRY ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
31,362 | $24,231,535 | |
| 2 | IDYA |
IDEAYA Biosciences, Inc.
|
280,261 | $9,338,296 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
62,545 | $6,082,501 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
727,154 | $5,839,046 | |
| 5 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
1,716,193 | $4,856,826 | |
| 6 | VALN |
Valneva SE
|
354,361 | $2,214,756 |
All Filings in SPRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,839,046 | 727,154 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,523,522 | 559,959 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||